Viral vectors have become increasingly favored by researchers due to their efficiency in delivering genetic material into target cells and their ability for stable gene expression. Engineered to reduce immunogenicity, these vectors offer a safe means for delivering therapeutic genes, making them pivotal in gene therapy research and the development of vaccines.
Achieving optimal use of viral vectors requires the establishment of a robust pipeline to produce them, a capability we proudly offer with jetOPTIMUS®. Indeed, jetOPTIMUS® streamlines your research process, enabling you to efficiently transfect DNA for an optimized small-scale virus production.
Discover Our Applications
Cell & Gene Therapy
Success of Gene and Cell Therapies is dependent on efficient production of viral vectors that require optimized transfection reagents and viral vector engineering
RNA/DNA Therapeutics
RNA/DNA in vivo delivery is the most powerful alternative to viral vectors for nucleic acid-based therapies. They offer substantial advantages in terms of reliability,safety and costs for nucleic-acid based therapies
Protein Production
Broad range of solutions is needed for manufacturing of functional proteins or antibodies at the desired scale in bacteria, yeast and mammalian cell expression systems
Life Sciences
Optimised plasmid engineering and specific transfection reagents are key to enable protein expression in a wide range of adherent and suspension mammalian cell types